Cargando…
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study
The aim of this study was to assess the short-term cardiometabolic outcomes in type 2 diabetes patients receiving empagliflozin in a tertiary referral center. Three hundred and fifteen consecutive patients started on empagliflozin were followed for a 4-month period after local ethics committee appro...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262422/ https://www.ncbi.nlm.nih.gov/pubmed/34169909 http://dx.doi.org/10.4103/ijp.IJP_669_18 |